METTL3 and breast cancer: Taken together, we hypothesized that METTL3 expression was up-regulated to induced docetaxel resistance in breast cancer by activating the expression of LINC00662; moreover, LINC00662 sponged miR-186-5p to further increase the expression of METTL3.